InVivo Therapeutics and The Miami Project to Cure Paralysis form strategic research collaboration

Thursday, May 5, 2011

InVivo Therapeutics, a company focused on the development of technologies for the treatment of spinal cord injuries (SCI), and The University of Miami Miller School of Medicine’s Miami Project to Cure Paralysis, a spinal cord injury research center, have entered into a strategic research collaboration for the development of novel SCI treatments.

The collaboration will evaluate InVivo’s biopolymer devices synergistically combined with cellular therapies, including The Miami Project’s Schwann cell technologies.

Key components of the research collaboration agreement include in vitro and in vivo studies with combinations of biomaterials, Schwann cells and other cellular therapies and drugs; joint ownership of resulting intellectual property; and the right of first offer for InVivo to license and commercialize on a worldwide exclusive basis.

 

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!